$175 Million is the total value of Velan Capital Investment Management LP's 18 reported holdings in Q2 2024. The portfolio turnover from Q1 2024 to Q2 2024 was 66.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ALIMERA SCIENCES INC | $75,663,443 | +42.6% | 13,608,533 | 0.0% | 43.35% | +79.9% | ||
| JASPER THERAPEUTICS INC | $32,547,896 | -22.7% | 1,471,904 | 0.0% | 18.65% | -2.5% | ||
| HRTX | HERON THERAPEUTICS INC | $24,453,604 | +26.4% | 6,986,744 | 0.0% | 14.01% | +59.4% | |
| PRAXIS PRECISION MEDICINES I | $14,503,546 | -32.2% | 350,666 | 0.0% | 8.31% | -14.5% | ||
| TOURMALINE BIO INC | $4,103,369 | -43.8% | 319,080 | 0.0% | 2.35% | -29.1% | ||
| TELA | TELA BIO INC | $3,506,609 | -17.1% | 746,087 | 0.0% | 2.01% | +4.6% | |
| RZLT | Buy | REZOLUTE INC | $3,440,000 | +237.3% | 800,000 | +100.0% | 1.97% | +325.7% |
| New | SKYE BIOSCIENCE INC | $3,381,357 | – | 422,142 | +100.0% | 1.94% | – | |
| OPTN | Sell | OPTINOSE INC | $2,592,543 | -40.8% | 2,492,830 | -16.9% | 1.48% | -25.4% |
| New | CONTEXT THERAPEUTICS INC | $2,587,098 | – | 1,290,323 | +100.0% | 1.48% | – | |
| NSPR | INSPIREMD INC | $2,255,824 | +5.3% | 904,029 | 0.0% | 1.29% | +32.8% | |
| Sell | OUTLOOK THERAPEUTICS INC | $1,823,480 | -69.5% | 247,084 | -50.6% | 1.04% | -61.5% | |
| ELEV | Buy | ELEVATION ONCOLOGY INC | $1,612,707 | -36.8% | 597,299 | +20.1% | 0.92% | -20.3% |
| TARA | New | PROTARA THERAPEUTICS INC | $998,400 | – | 480,000 | +100.0% | 0.57% | – |
| New | KIORA PHARMACEUTICALS INC | $513,337 | – | 122,223 | +100.0% | 0.29% | – | |
| XFOR | New | X4 PHARMACEUTICALS INC | $382,232 | – | 659,020 | +100.0% | 0.22% | – |
| ASLAN PHARMACEUTICALS LTDspon ads new | $187,500 | -51.2% | 625,000 | 0.0% | 0.11% | -38.9% | ||
| Exit | KIORA PHARMACEUTICALS INC | $0 | – | -1,100,000 | -100.0% | -0.35% | – | |
| Exit | ENVVENO MEDICAL CORPORATION | $0 | – | -172,235 | -100.0% | -0.42% | – | |
| MIST | Exit | MILESTONE PHARMACEUTICALS IN | $0 | – | -650,000 | -100.0% | -0.53% | – |
| GERN | Exit | GERON CORP | $0 | – | -500,000 | -100.0% | -0.75% | – |
| AQST | Exit | AQUESTIVE THERAPEUTICS INC | $0 | – | -600,000 | -100.0% | -1.16% | – |
| INSP | Exit | INSPIRE MED SYS INC | $0 | – | -18,000 | -100.0% | -1.76% | – |
| ADMA | Exit | ADMA BIOLOGICS INC | $0 | – | -1,528,601 | -100.0% | -4.58% | – |
| XBI | Exit | SPDR SER TRput | $0 | – | -150,000 | -100.0% | -6.46% | – |
| IWM | Exit | ISHARES TRput | $0 | – | -100,000 | -100.0% | -9.55% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2024-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| TELA BIO INC | 11 | Q2 2024 | 7.6% |
| ADMA BIOLOGICS INC | 10 | Q1 2024 | 13.7% |
| OPTINOSE INC | 10 | Q2 2024 | 7.9% |
| REZOLUTE INC | 10 | Q2 2024 | 2.0% |
| ALIMERA SCIENCES INC | 9 | Q2 2024 | 43.3% |
| LANTHEUS HLDGS INC | 9 | Q4 2023 | 18.0% |
| JASPER THERAPEUTICS INC | 9 | Q4 2023 | 17.8% |
| HERON THERAPEUTICS INC | 7 | Q2 2024 | 14.0% |
| IMMUNOCORE HLDGS PLC | 6 | Q1 2023 | 13.7% |
| QUIPT HOME MEDICAL CORP | 6 | Q3 2023 | 4.8% |
View Velan Capital Investment Management LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2024-11-07 |
| 4 | 2024-09-16 |
| SC 13D/A | 2024-09-16 |
| N-PX | 2024-08-29 |
| 13F-HR | 2024-08-14 |
| SC 13D/A | 2024-05-16 |
| 13F-HR | 2024-05-14 |
| SC 13G | 2024-03-28 |
| 13F-HR | 2024-02-14 |
| 4 | 2024-02-09 |
View Velan Capital Investment Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.